1.465
Schlusskurs vom Vortag:
$1.52
Offen:
$1.47
24-Stunden-Volumen:
757.44K
Relative Volume:
0.57
Marktkapitalisierung:
$280.84M
Einnahmen:
$156.37M
Nettoeinkommen (Verlust:
$-37.49M
KGV:
-6.9762
EPS:
-0.21
Netto-Cashflow:
$-47.77M
1W Leistung:
-2.00%
1M Leistung:
-6.37%
6M Leistung:
+8.89%
1J Leistung:
-5.77%
Cerus Corp Stock (CERS) Company Profile
Firmenname
Cerus Corp
Sektor
Branche
Telefon
(925) 288-6000
Adresse
1220 CONCORD AVENUE, CONCORD, CA
Vergleichen Sie CERS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
CERS
Cerus Corp
|
1.465 | 291.38M | 156.37M | -37.49M | -47.77M | -0.21 |
|
ABT
Abbott Laboratories
|
125.31 | 215.34B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.50 | 146.15B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
362.72 | 136.97B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
90.13 | 115.69B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
84.10 | 48.77B | 5.88B | 1.34B | 577.90M | 2.3455 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-04-12 | Eingeleitet | Craig Hallum | Buy |
| 2023-01-20 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-01-17 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Fortgesetzt | BTIG Research | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Eingeleitet | BTIG Research | Buy |
| 2019-11-13 | Hochstufung | BTIG Research | Neutral → Buy |
| 2019-08-28 | Eingeleitet | Stifel | Buy |
| 2019-08-23 | Fortgesetzt | Stephens | Overweight |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Fortgesetzt | BTIG Research | Neutral |
| 2016-07-07 | Fortgesetzt | Cantor Fitzgerald | Buy |
| 2015-12-17 | Herabstufung | Wedbush | Outperform → Neutral |
| 2014-05-02 | Bestätigt | MLV & Co | Buy |
| 2013-04-24 | Bestätigt | Cantor Fitzgerald | Buy |
| 2013-03-15 | Bestätigt | MLV & Co | Buy |
| 2012-04-17 | Eingeleitet | Cantor Fitzgerald | Buy |
| 2012-02-29 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Bestätigt | MLV & Co | Buy |
| 2011-06-03 | Eingeleitet | Wedbush | Outperform |
| 2011-03-04 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Hochstufung | Avondale | Mkt Perform → Mkt Outperform |
Alle ansehen
Cerus Corp Aktie (CERS) Neueste Nachrichten
Can Cerus Corporation stock hit analyst price targetsJuly 2025 Summary & Scalable Portfolio Growth Methods - newser.com
Live market analysis of Cerus CorporationJuly 2025 Sector Moves & Safe Swing Trade Setups - newser.com
Relative strength of Cerus Corporation in sector analysisMarket Risk Analysis & Growth Focused Stock Reports - newser.com
Will Cerus Corporation stock reach Wall Street targetsGlobal Markets & Entry Point Confirmation Signals - newser.com
How Cerus Corporation (CU2) stock trades pre earningsJuly 2025 Selloffs & Low Drawdown Investment Strategies - newser.com
Tools to monitor Cerus Corporation recovery probabilityInflation Watch & Daily Oversold Bounce Ideas - newser.com
Is Cerus Corporation reversing from oversold territory2025 Price Momentum & Community Verified Trade Alerts - newser.com
What does recent volatility data suggest for Cerus CorporationJuly 2025 Intraday Action & Growth Focused Entry Point Reports - newser.com
Signal strength of Cerus Corporation stock in tech scannersWeekly Trade Report & Low Drawdown Momentum Ideas - newser.com
Will Cerus Corporation (CU2) stock outperform small cap peersPortfolio Risk Summary & Fast Moving Trade Plans - newser.com
Can Cerus Corporation stock hit record highs againJuly 2025 Update & AI Forecast Swing Trade Picks - newser.com
How buyback programs support Cerus Corporation (CU2) stockMarket Movers & Fast Entry Momentum Trade Alerts - newser.com
Is Cerus Corporation stock a buy for dividend growthChart Signals & Capital Protection Trade Alerts - newser.com
Why Cerus Corporation stock is trending among retail tradersMarket Sentiment Report & High Accuracy Swing Trade Signals - newser.com
Is Cerus Corporation CU2 a good long term investmentHigh Dividend Yield Stocks & Wealth Building Starts With One Click - earlytimes.in
Why Cerus Corporation stock is popular among millennialsWeekly Risk Report & Safe Capital Preservation Plans - newser.com
Real time pattern detection on Cerus Corporation stockWeekly Investment Report & Community Trade Idea Sharing - newser.com
Cerus Shares Face Critical Test with Quarterly Results - AD HOC NEWS
IQ EQ FUND MANAGEMENT IRELAND Ltd Has $518,000 Position in Cerus Corporation $CERS - MarketBeat
What makes Cerus Corporation stock attractive to growth fundsEarnings Trend Report & Daily Growth Stock Tips - newser.com
Cwm LLC Buys 29,483 Shares of Cerus Corporation $CERS - Defense World
Sumitomo Mitsui Trust Group Inc. Sells 121,052 Shares of Cerus Corporation $CERS - Defense World
Volatility clustering patterns for Cerus CorporationIPO Watch & High Return Stock Watch Alerts - newser.com
Cerus Corporation (CERS) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Cerus (CERS) Projected to Post Quarterly Earnings on Thursday - MarketBeat
Finanzdaten der Cerus Corp-Aktie (CERS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cerus Corp-Aktie (CERS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jensen Chrystal | Chief Legal Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
783,294 |
| Jensen Chrystal | Chief Legal Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
813,369 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 14 '25 |
Sale |
1.45 |
46,004 |
66,706 |
1,431,326 |
| Jayaraman Vivek K | Chief Operating Officer |
Mar 13 '25 |
Sale |
1.45 |
29,985 |
43,478 |
1,477,330 |
| Greenman William Mariner | President and CEO |
Mar 14 '25 |
Sale |
1.45 |
122,827 |
178,099 |
4,115,845 |
| Greenman William Mariner | President and CEO |
Mar 13 '25 |
Sale |
1.45 |
71,086 |
103,075 |
4,238,672 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 14 '25 |
Sale |
1.45 |
36,740 |
53,273 |
875,867 |
| Green Kevin Dennis | Chief Financial Officer |
Mar 13 '25 |
Sale |
1.45 |
23,147 |
33,563 |
912,607 |
| Benjamin Richard J | Chief Medical Officer |
Mar 14 '25 |
Sale |
1.45 |
30,075 |
43,609 |
685,775 |
| Benjamin Richard J | Chief Medical Officer |
Mar 13 '25 |
Sale |
1.45 |
18,949 |
27,476 |
715,850 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):